Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Sep;159(3):937-43.
doi: 10.1016/s0002-9440(10)61769-5.

The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains

Affiliations

The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains

M L Schmidt et al. Am J Pathol. 2001 Sep.

Abstract

A novel Congo red-derived fluorescent probe (trans, trans),-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB) that binds to amyloid plaques of postmortem Alzheimer's disease brains and in transgenic mouse brains in vivo was designed as a prototype imaging agent for Alzheimer's disease. In the current study, we used BSB to probe postmortem tissues from patients with various neurodegenerative diseases with diagnostic lesions characterized by fibrillar intra- or extracellular lesions and compared these results with standard histochemical dyes such as thioflavin S and immunohistochemical stains specific for the same lesions. These data show that BSB binds not only to extracellular amyloid beta protein, but also many intracellular lesions composed of abnormal tau and synuclein proteins and suggests that radioiodinated BSB derivatives or related ligands may be useful imaging agents to monitor diverse amyloids in vivo.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic illustration of BSB.
Figure 2.
Figure 2.
Neurodegenerative lesions composed of Aβ protein. This figure depicts tissue sections of frontal cortex immunostained with MAB. BCO5, first column; BA27, second column; 4G8, third column, or stained with BSB, fourth column; and THIOS, fifth column. The first row (A–E) shows an AD case, the second row (F–J) shows a DS case with AD, and the third row (K–M) shows a case of FAD with a mutation in PS2. The asterisks indicate the blood vessel that was used as landmark to identify the same area in each set of consecutive sections. The arrows point to the same subpial Aβ deposit. All images were taken at the same magnification. Scale bar, 100 μm.
Figure 3.
Figure 3.
Neurodegenerative lesions composed of tau protein. This figure shows tau immunoreactive lesions in various neurodegenerative diseases stained with BSB and THIOS. All sections in the first row (A–F) were stained with BSB and all sections in the second row (G–L) were stained with THIOS. In the third row the sections depicted in panels M and N are stained with BSB and in panels O to Q are immunostained with antiserum 17026. A and G: NFTs and Aβ plaques from an AD patient. B and H: Coiled bodies in the midbrain of a patient with PSP. C and I: Globose tangles in the midbrain of a patient with PSP. D and J: Pick bodies in the dentate gyrus of a patient with Pick’s disease. E, K, and P: Consecutive sections through the pons of a FTDP-17 (N279K) patient. P shows tau-positive neurons and neuropil threads. Both BSB and THIOS stain some neuropil threads in adjacent sections (E and K, respectively) but tau immunopositive neurons are not stained. Asterisks indicate the same blood vessel in these images and the arrows point to NTs. F, L, and Q: Coiled bodies in a patient with familial PSG (exon 10 + 16 mutation). M: NT pathology in a CBD patient. N and O: Tau and BSB stained glia (arrows) in the amygdala of a FTDP-17 (P301L) patient. A, C, G, I, and M are the same magnification; scale bar in A = 20 μm. B, H, L, and Q are the same magnification; scale bar in L = 10 μm. D, F, J, N, and O are the same magnification; scale bar in N = 10 μm. E, K, and P are the same magnification; scale bar in P = 50 μm.
Figure 4.
Figure 4.
Neurodegenerative lesions composed of α-synuclein. The first column of this figure depicts tissue sections immunostained with Syn303. The second and third columns show tissue sections stained with BSB and THIOS, respectively. A to C: Cerebellar white matter flanked on the top and the bottom by granule cell layers of a patient with MSA. Arrows point to CGIs in each of the three panels. D: Several cortical LBs in the cingulate cortex of a patient with DLB/PD. In contrast to the α-synuclein antibody, BSB (E) and THIOS (F) stain only a few LBs in adjacent tissue sections. Arrows point to LBs in all three panels. G: A large number of α-synuclein-positive inclusions in the CA3 region of the hippocampus of a patient with NBIA-1. H and I were taken from adjacent tissue sections and show rare globules but no perikaryal inclusions. All panels are the same magnification; scale bar in A = 20 μm.

References

    1. Skovronsky DM, Zhang B, Kung M-P, Kung HF, Trojanowski JQ, Lee VMY: In vivo detection of amyloid plaques in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 2000, 97:7609-7614 - PMC - PubMed
    1. Klunk WE, Debnath ML, Pettegrew JW: Development of small molecule probes for the β-amyloid protein of Alzheimer’s disease. Neurobiol Aging 1994, 15:691-698 - PubMed
    1. Klunk WE, Debnath ML, Pettegrew JW: Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiol Aging 1995, 16:541-548 - PubMed
    1. Styren SD, Hamilton RL, Styren GC, Klunk WE: X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer’s disease pathology. J Histochem Cytochem 2000, 48:1223-1232 - PubMed
    1. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: evidence that an initially deposited Aβ species is Aβ1–42(43). Neuron 1994, 13:45-53 - PubMed

Publication types